Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial.

J L Welsh; B A Wagner; T J van't Erve; P S Zehr; D J Berg; T R Halfdanarson; N S Yee; K L Bodeker; J Du; L J Roberts

doi:10.1007/s00280-013-2070-8

Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial.

Identifier:nobleid.org/w1/20260515/CBA0F70D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CBA0F70D.svg?ark=w1%2F20260515%2FCBA0F70D)](https://nobleid.org/work/w1/20260515/CBA0F70D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial.

Identifier:nobleid.org/w1/20260515/CBA0F70D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CBA0F70D.svg?ark=w1%2F20260515%2FCBA0F70D)](https://nobleid.org/work/w1/20260515/CBA0F70D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work